Literature DB >> 20876414

Use of proton pump inhibitors and mortality among institutionalized older people.

J Simon Bell, Timo E Strandberg, Mariko Teramura-Gronblad, Jouko V Laurila, Reijo S Tilvis, Kaisu H Pitkälä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20876414     DOI： 10.1001/archinternmed.2010.304

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  13 in total

1.  Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals.

Authors:  R Schepisi; S Fusco; F Sganga; B Falcone; D L Vetrano; A Abbatecola; F Corica; M Maggio; C Ruggiero; P Fabbietti; A Corsonello; G Onder; F Lattanzio
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Proton pump inhibitors and risk of readmission and mortality in older patients discharged from a tertiary hospital to residential aged care facilities.

Authors:  Matthew A Pegoli; Maneesha Dedigama; Arduino A Mangoni; Patrick T Russell; Luke E Grzeskowiak; Tilenka Thynne
Journal:  Ther Adv Drug Saf       Date:  2016-11-29

3.  Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.

Authors:  Laura E Targownik; Andrew L Goertzen; Yunhua Luo; William D Leslie
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

Review 4.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.

Authors:  J Simon Bell; Heidi T Taipale; Helena Soini; Kaisu H Pitkälä
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals.

Authors:  Marcello Maggio; Andrea Corsonello; Gian Paolo Ceda; Chiara Cattabiani; Fulvio Lauretani; Valeria Buttò; Luigi Ferrucci; Stefania Bandinelli; Angela Marie Abbatecola; Liana Spazzafumo; Fabrizia Lattanzio
Journal:  JAMA Intern Med       Date:  2013-04-08       Impact factor: 21.873

7.  Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial.

Authors:  Kaisu H Pitkala; Anna-Liisa Juola; Helena Soini; Marja-Liisa Laakkonen; Hannu Kautiainen; Mariko Teramura-Gronblad; Harriet Finne-Soveri; Mikko Bjorkman
Journal:  Trials       Date:  2012-06-18       Impact factor: 2.279

8.  Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.

Authors:  Pradeep Arora; Anu Gupta; Mojgan Golzy; Nilang Patel; Randolph L Carter; Kabir Jalal; James W Lohr
Journal:  BMC Nephrol       Date:  2016-08-03       Impact factor: 2.388

9.  Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.

Authors:  Steven P Dunn; Steven R Steinhubl; Deborah Bauer; Richard J Charnigo; Peter B Berger; Eric J Topol
Journal:  J Am Heart Assoc       Date:  2013-01-15       Impact factor: 5.501

10.  Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Yan Yan; Ziyad Al-Aly
Journal:  BMJ Open       Date:  2017-07-04       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.